BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21838461)

  • 1. Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis.
    Binotto G; Cillo U; Trentin L; Piazza F; Zaninotto M; Semenzato G; Adami F
    Amyloid; 2011 Jun; 18 Suppl 1():132-4. PubMed ID: 21838461
    [No Abstract]   [Full Text] [Related]  

  • 2. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for AL amyloidosis.
    Guillaume B; Straetmans N; Jadoul M; Cosyns JP; Ferrant A
    Bone Marrow Transplant; 1997 Nov; 20(10):907-8. PubMed ID: 9404936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem cell transplantation in amyloidosis AL.
    Majolino I; Marceno R; Pecoraro G; Scime R; Vasta S; Liberti G; Rizzo A; Indovina A; Caronia F
    Bone Marrow Transplant; 1993 Jan; 11(1):85. PubMed ID: 8094310
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis.
    Meier-Ewert HK; Sanchorawala V; Berk J; Finn KT; Skinner M; Seldin DC; Ruberg FL
    Amyloid; 2011 Jun; 18 Suppl 1():130-1. PubMed ID: 21838460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is early diagnosis of amyloidosis AL possible? Consideration on a representative case].
    Vivaldi P
    Recenti Prog Med; 1996 Apr; 87(4):158-60. PubMed ID: 8643876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis.
    Perfetti V; Ubbiali P; Magni M; Colli Vignarelli M; Casarini S; Matteucci P; Gianni AM; Merlini G
    Bone Marrow Transplant; 1999 Feb; 23(4):323-7. PubMed ID: 10100575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
    Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
    Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
    Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
    Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
    Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
    Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal light chain restricted primary intrapulmonary nodular amyloidosis.
    Ross P; Magro CM
    Ann Thorac Surg; 2005 Jul; 80(1):344-7. PubMed ID: 15975406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver involvement with rapidly progressive course in light chain (AL) amyloidosis: distinguishing features at presentation. Experience of a single center.
    Econimo L; Jeannin G; Biasi L; Mazzola G; Mendeni M; Presteni K; Gregorini G
    Amyloid; 2011 Jun; 18 Suppl 1():109-11. PubMed ID: 21838452
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
    Seldin DC; Andrea N; Berenbaum I; Berk JL; Connors L; Dember LM; Doros G; Fennessey S; Finn K; Girnius S; Lerner A; Libbey C; Meier-Ewert HK; O'Connell R; O'Hara C; Quillen K; Ruberg FL; Sam F; Segal A; Shelton A; Skinner M; Sloan JM; Wiesman JF; Sanchorawala V
    Amyloid; 2011 Jun; 18 Suppl 1(Suppl 1):127-9. PubMed ID: 21838459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
    Hayes-Lattin BM; Curtin PT; Fleming WH; Leis JF; Stepan DE; Schubach S; Maziarz RT
    Bone Marrow Transplant; 2002 Sep; 30(5):279-85. PubMed ID: 12209349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
    Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
    Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of autologous stem cell transplantation for AL amyloidosis in one Czech center.
    Ryšavá R; Straub J; Vacková B; Kořen J; Trněný M; Potyšová Z; Špička I
    Amyloid; 2011 Jun; 18 Suppl 1():139-41. PubMed ID: 21838464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.